[Clinical study of an antimitotic antibiotic: rufochromomycin (R.P. 5,278). On 166 cases. Value in malignant reticulopathies].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000188:drug therapy*; D013945:Thymoma / Q000188:drug therapy*
D000903:Antibiotics, Antineoplastic
Etude clinique d'un antibiotique antimitotique: la rufocromomycine (5.278 R.P.). Sur 166 observations. Intérêt dans les réticulopathies malignes.